Dmitry S. Petelin , Aynur A. Ragimova , Kamilya R. Gizetdinova , Alexandr O. Viazmin , Egor A. Borisenko , Beatrice A. Volel
Abstract
Functional neurological disorders are widely represented in clinical practice, but their etiology, pathogenesis, as well as approaches to diagnosis and therapy have not been sufficiently studied. This article provides an overview of the taxonomy and clinical manifestations of functional neurological disorders. Modern data on the diagnosis of the discussed group of disorders are also presented, with an emphasis on instrumental methods – electroencephalography, transcranial magnetic stimulation, functional magnetic resonance imaging. The available data on evidence-based approaches to the treatment of functional neurological disorders are summarized. The main points of the literature review are illustrated by clinical observation.
Keywords: functional neurological disorders, electroencephalography, transcranial magnetic stimulation, functional magnetic resonance imaging.
Keywords: functional neurological disorders, electroencephalography, transcranial magnetic stimulation, functional magnetic resonance imaging.
About the Author
Dmitry S. Petelin 1 , Aynur A. Ragimova 2 , Kamilya R. Gizetdinova 3 , Alexandr O. Viazmin 4 , Egor A. Borisenko 1 , Beatrice A. Volel 51 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
2 National Research University Higher School of Economics, Moscow, Russia; Research center of neurology, Moscow, Russia
3 Kazan Federal University, Kazan, Russia
4 National Research University Higher School of Economics, Moscow, Russia
5 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Mental health research center, Moscow, Russia
References
1. Mishra A, Pandey S. Functional Neurological Disorders: Clinical Spectrum, Diagnosis, and Treatment. Neurologist. 2022;27(5):276-89. DOI: 10.1097/NRL.0000000000000453
2. Bennett K, Diamond C, Hoeritzauer I et al. A practical review of functional neurological disorder (FND) for the general physician. Clin Med (Lond). 2021;21(1):28-36. DOI: 10.7861/clinmed.2020-0987
3. O’Mahony B, Nielsen G, Baxendale S et al. Economic Cost of Functional Neurologic Disorders: A Systematic Review. Neurology. 2023;101(2): 202-14. DOI: 10.1212/WNL.0000000000207388
4. Kola S, LaFaver K. Updates in Functional Movement Disorders: from Pathophysiology to Treatment Advances. Curr Neurol Neurosci Rep. 2022;22(5):305-11. DOI: 10.1007/s11910-022-01192-9
5. Sharma VD, Jones R, Factor SA. Psychodynamic Psychotherapy for Functional (Psychogenic) Movement Disorders. J Mov Disord. 2017;10(1):40-4. DOI: 10.14802/jmd.16038
6. Gelauff J, Stone J, Edwards M et al. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol, Neurosurge, Psychiatry. 2014;85(2):220-6. DOI: 10.1136/jnnp-2013-305321
7. Asadi-Pooya AA, Hallett M, Mirzaei Damabi N, Fazelian Dehkordi K. Genetics of Functional Seizures; A Scoping Systematic Review. Genes (Basel). 2023;14(8), 1537. DOI: 10.3390/genes14081537
8. Ludwig L, Pasman JA, Nicholson T et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry. 2018;5(4):307–320. DOI: 10.1016/S2215-0366(18)30051-8
9. Drane DL, Fani N, Hallett M et al. A framework for understanding the pathophysiology of functional neurological disorder. CNS Spectr. 2020;4:1-7. DOI: 10.1017/S1092852920001789
10. Shishorin R, Gamirova A, Tolmacheva V et al. The onset of functional movement disorders after COVID-19: A case series. Indian J Psychiatry. 2022;64(5):529-32. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_327_22
11. Macchi ZA, Kletenik I, Olvera C et al. Psychiatric Comorbidities in Functional Movement Disorders: A Retrospective Cohort Study. Mov Disord Clin Pract. 2021;8(5):725-32. DOI:10.1002/mdc3.13226
12. O’Connell N, Nicholson T, Blackman G et al. Medication prescriptions in 322 motor functional neurological disorder patients in a large UK mental health service: A case control study. Gen Hosp Psychiatry. 2019;58:94-102. DOI:10.1016/j.genhosppsych.2019.04.004
13. Patwal R, Jolly AJ, Kumar A et al. Diagnostic accuracy of clinical signs and investigations for functional weakness, sensory and movement disorders: A systematic review. J Psychosom Res. 2023;168:111196. DOI: 10.1016/j.jpsychores.2023.111196
14. Deecke L. Bereitschaftspotential as an indicator of movement preparation in supplementary motor area and motor cortex. Ciba Found Symp. 1987;132:231-50. DOI: 10.1002/9780470513545.ch14
15. Beudel M, Zutt R, Meppelink AM et al. Improving neurophysiological biomarkers for functional myoclonic movements. Parkinsonism Relat Disord. 2018;51:3-8. DOI: 10.1016/j.parkreldis.2018.03.029
16. Meppelink AM, Little S, Oswal A s et al. Event related desynchronisation predicts functional propriospinal myoclonus. Parkinsonism Relat Disord. 2016;31:116-8. DOI: 10.1016/j.parkreldis.2016.07.010
17. van der Salm SMA, Tijssen MAJ, Koelman JHTM et al. The bereitschaftspotential in jerky movement disorders. J Neurol Neurosurg Psychiatry. 2012; 83(12):1162-7. DOI: 10.1136/jnnp-2012-303081
18. Terada K, Ikeda A, Van Ness PC et al. Presence of Bereitschaftspotential preceding psychogenic myoclonus: clinical application of jerk-locked back averaging. J Neurol Neurosurg Psychiatry. 1995; 58(6):745-7. DOI: 10.1136/jnnp.58.6.745
19. Erro R, Bhatia KP, Edwards MJ et al. Clinical diagnosis of propriospinal myoclonus is unreliable: an electrophysiologic study. Mov Disord. 2013;28(13):1868-73. DOI:10.1002/mds.25627
20. Esposito M, Edwards MJ, Bhatia KP et al. Idiopathic spinal myoclonus: a clinical and neurophysiological assessment of a movement disorder of uncertain origin. Mov Disord. 2009; 24(16):2344–2349. DOI: 10.1002/mds.22812
21. Thomsen BLC, Teodoro T, Edwards MJ. Biomarkers in functional movement disorders: a systematic review. J Neurol Neurosurg Psychiatry. 2020;91(12):1261-9. DOI: 10.1136/jnnp-2020-323141
22. Teodoro T, Koreki A, Meppelink AM et al. Contingent negative variation: a biomarker of abnormal attention in functional movement disorders. Eur J Neurol. 2020;27:985-94. DOI: 10.1111/ene.14189
23. Blakemore RL, Hyland BI, Hammond-Tooke GD et al. Deficit in late-stage contingent negative variation provides evidence for disrupted movement preparation in patients with conversion paresis. Biol Psychol. 2015;109:73-85. DOI: 10.1016/j.biopsycho.2015.04.009
24. Macerollo A, Chen J-C, Pareés I et al. Sensory attenuation assessed by sensory evoked potentials in functional movement disorders. PLoS One. 2015;10(6):e0129507. DOI: 10.1371/journal.pone.0129507
25. Brum M, Cabib C, Valls-Solé J. Clinical value of the assessment of changes in MEP duration with voluntary contraction. Front Neurosci. 2015;9:505. DOI: 10.3389/fnins.2015.00505
26. Liepert J, Hassa T, Tüscher O et al. Abnormal motor excitability in patients with psychogenic paresis. A TMS study. J Neurol. 2009;256(1):121-6. DOI: 10.1007/s00415-009-0090-4
27. Liepert J, Hassa T, Tüscher O et al. Electrophysiological correlates of motor conversion disorder. Mov Disord. 2008;23(15):2171-6. DOI: 10.1002/mds.21994
28. Liepert J, Hassa T, Tüscher O et al. Motor excitability during movement imagination and movement observation in psychogenic lower limb paresis. J Psychosom Res. 2011;70(1):59-65. DOI: 10.1016/j.jpsychores.2010.06.004
29. Pick S, Goldstein LH, Perez DL et al. Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda. J Neurol Neurosurg Psychiatry. 2019;90:704-11. DOI:10.1136/jnnp-2018-319201
30. Aybek S, Nicholson TR, Zelaya F et al. Neural Correlates of Recall of Life Events in Conversion Disorder. JAMA Psychiatry. 2014;71(1):52–60. DOI:10.1001/jamapsychiatry.2013.2842
31. Aybek S, Nicholson TR, O’Daly O. Emotion-Motion Interactions in Conversion Disorder: An fMRI Study. PLoS ONE. 2015;10(4): e0123273. DOI: 10.1371/journal.pone.0123273
32. Espay AJ, Maloney T, Vannest J et al. Impaired emotion processing in functional (psychogenic) tremor: A functional magnetic resonance imaging study. Neuroimage Clin. 2018;17:179-87. DOI:10.1016/j. nicl.2017.10.020
33. Hassa T, Sebastian A, Liepert J et al. Symptom-specific amygdala hyperactivity modulates motor control network in conversion disorder. NeuroImage Clin. 2017;15:143-50. DOI: 10.1016/j.nicl.2017.04.004
34. Morris LS, To B, Baek K et al. Disrupted avoidance learning in functional neurological disorder: Implications for harm avoidance theories. Neuroimage Clin. 2017;16:286-94. DOI: 10.1016/j.nicl.2017.08.007
35. Voon V, Brezing C, Gallea C et al. Emotional stimuli and motor conversion disorder. Brain. 2010;33:1526-36. DOI: 10.1093/brain/awq054
36. Allendorfer JB, Nenert R, Hernando KA et al. FMRI response to acute psychological stress differentiates patients with psychogenic non-epileptic seizures from healthy controls. A biochemical and neuroimaging biomarker study. Neuroimage Clin. 2019;24:101967. DOI: 10.1016/j.nicl.2019.101967
37. Balachandran N, Goodman AM, Allendorfer JB et al. Relationship between neural responses to stress and mental health symptoms in psychogenic nonepileptic seizures after traumatic brain injury. Epilepsia. 2021;62:107-19. DOI: 10.1111/epi.16758
38. Espay AJ, Maloney T, Vannest J et al. Dysfunction in emotion processing underlies functional (psychogenic) dystonia. Mov Disord. 2018;33(1):136-45. DOI:10.1002/mds.27217
39. Cojan Y, Waber L, Carruzzo A et al. Motor inhibition in hysterical conversion paralysis. Neuroimage. 2019;47:1026-37. DOI: 10.1016/j.neuroimage.2009.05.023
40. Stone J, Zeman A, Simonotto E et al. Sharpe FMRI in patients with motor conversion symptoms and controls with simulated weakness. Psychosom Med. 2007;69(9):961-9. DOI: 10.1097/PSY.0b013e31815b6c14
41. Voon V, Brezing C, Gallea C et al. Aberrant supplementary motor complex and limbic activity during motor preparation in motor conversion disorder. Mov Disord. 2011;26(13):2396-403. DOI: 10.1002/mds. 23890
42. Bègue I, Blakemore R, Klug J et al. Metacognition of visuomotor decisions in conversion disorder. Neuropsychologia. 2018;114:251-65. DOI: 10.1016/j.neuropsychologia.2018.04.018
43. Deeley Q, Oakley DA, Toone B et al. Halligan The functional anatomy of suggested limb paralysis. Cortex. 2013;49(2):411-22. DOI: 10.1016/j.cortex.2012.09.016
44. Edwards MJ, Adams RA, Brown H et al. A Bayesian account of ‚hysteria‘. Brain. 2012;135(11):3495-512. DOI: 10.1093/brain/aws129
45. Schrag AE, Mehta AR, Bhatia KP et al. The functional neuroimaging correlates of psychogenic versus organic dystonia. Brain. 2013;136:770-81. DOI: 10.1093/brain/awt008
46. Voon V, Cavanna AE, Coburn K et al. Functional neuroanatomy and neurophysiology of functional neurological disorders (Conversion Disorder). J Neuropsychiatry Clin Neurosci. 2016;28(3):168-90. DOI: 10.1176/appi.neuropsych.14090217
47. Fiorio M, Braga M, Marotta A et al. (2022). Functional neurological disorder and placebo and nocebo effects: shared mechanisms. Nat Rev Neurol. 2022;18(10):624-35. DOI: 10.1038/s41582-022-00711-z
48. Goldstein LH, Robinson EJ, Mellers JDC et al. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial. Lancet Psychiatry. 2020;7(6):491-505. DOI: 10.1016/S2215-0366(20)30128-0
49. Varley D, Sweetman J, Brabyn S et al. The clinical management of functional neurological disorder: A scoping review of the literature. J Psychosom Res. 2023;165:111121. DOI: 10.1016/j.jpsychores.2022.
111121
50. Alberto J. Espay, Thomas Maloney, Jennifer Vannest et al.Impaired emotion processing in functional (psychogenic) tremor. A functional magnetic resonance imaging study. NeuroImage: Clinical. 2018;17:179-87. DOI: 10.1016/j.nicl.2017.10.020
For citation:Petelin D.S., Ragimova A.A., Gizetdinova K.R., Viazmin A.O., Borisenko E.A., Volel B.A. Modern approaches to the diagnosis and treatment of functional neurological disorders: clinical case and literature review. Clinical review for general practice. 2024; 5 (5): 49–56 (In Russ.). DOI: 10.47407/kr2024.5.5.00406
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.